Scinai Immunotherapeutics (SCNI) Exchange Rate Effect (2018 - 2024)
Scinai Immunotherapeutics' (SCNI) quarterly Exchange Rate Effect came in at $2000.0 in Q4 2024, up 114.29% year-on-year from $933.33 in Q1 2024, and up 101.52% quarter-over-quarter from -$132000.0 in Q3 2024.
Scinai Immunotherapeutics (SCNI) Exchange Rate Effect (2018 - 2024) Analysis & Trends
Scinai Immunotherapeutics has disclosed Exchange Rate Effect across 7 years of filings, most recently posting $2000.0 for Q4 2024.
- Exchange Rate Effect for Q4 2024 came in at $2000.0, up 114.29% year-over-year; the trailing twelve-month figure through Dec 2024 was -$137000.0 (up 49.63% YoY), and the FY2025 annual result was $1000.0, up 111.11% from the prior year.
- Exchange Rate Effect came in at $2000.0 for Q4 2024 at Scinai Immunotherapeutics, up from -$132000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.0 million in Q3 2021 to a low of -$987000.0 in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$132000.0 (2024), against an average of $63352.9.
- Across the five-year window, Exchange Rate Effect soared 1210.67% in 2021 and slumped 1985.71% in 2024, its largest moves.
- Scinai Immunotherapeutics' Exchange Rate Effect stood at $545000.0 in 2020, then plunged by 153.76% to -$293000.0 in 2021, then jumped by 48.46% to -$151000.0 in 2022, then soared by 90.73% to -$14000.0 in 2023, then soared by 114.29% to $2000.0 in 2024.
- The last three Exchange Rate Effect figures came in at $2000.0 (Q4 2024), -$132000.0 (Q3 2024), and -$14000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | -132,000.00 |
| Sep 30, 2024 | -132,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | -41,000.00 |
| Jun 30, 2023 | -41,000.00 |
| Mar 31, 2023 | -224,000.00 |
| Mar 31, 2023 | -224,000.00 |
| Dec 31, 2022 | -151,000.00 |
| Dec 31, 2022 | -151,000.00 |
| Sep 30, 2022 | -987,000.00 |
| Sep 30, 2022 | -987,000.00 |
| Jun 30, 2022 | 1.57 Mn |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | -359,000.00 |
| Mar 31, 2022 | -359,000.00 |